Soleus Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-169,000
| Closed | -$8.17M | – | 98 |
|
|
2025
Q1 | $8.17M | Sell |
169,000
-106,000
| -39% | -$5.13M | 0.59% | 41 |
|
|
2024
Q4 | $10.6M | Buy |
+275,000
| New | +$10.6M | 0.67% | 37 |
|
|
2024
Q2 | – | Sell |
-34,500
| Closed | -$998K | – | 107 |
|
|
2024
Q1 | $998K | Sell |
34,500
-48,500
| -58% | -$1.4M | 0.07% | 81 |
|
|
2023
Q4 | $1.9M | Buy |
+83,000
| New | +$1.9M | 0.21% | 55 |
|
|
2023
Q3 | – | Sell |
-39,800
| Closed | -$1.1M | – | 108 |
|
|
2023
Q2 | $1.1M | Buy |
+39,800
| New | +$1.1M | 0.12% | 83 |
|
|
2023
Q1 | – | Sell |
-236,000
| Closed | -$2.57M | – | 93 |
|
|
2022
Q4 | $2.57M | Buy |
+236,000
| New | +$2.57M | 0.37% | 52 |
|